In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli.

We investigated the activity of benzoxazinorifamycin (KRM-1648) against several drug-susceptible and multidrug-resistant strains of tubercle bacilli. Since KRM-1648 is a rifamycin derivative, we included some strains of Mycobacterium tuberculosis resistant to rifampin (RIF) among the multidrug-resis...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Luna-Herrera, J, Reddy, M V, Gangadharam, P R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162557/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7726512/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.2.440
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!